Sivelestat Sodium Alleviates Ischemia-Reperfusion-Induced Acute Kidney Injury via Suppressing TLR4/Myd88/NF-κB Signaling Pathway in Mice.

MLA

Wang, Jie, et al. “Sivelestat Sodium Alleviates Ischemia-Reperfusion-Induced Acute Kidney Injury via Suppressing TLR4/Myd88/NF-ΚB Signaling Pathway in Mice.” Drug Design, Development & Therapy, vol. 18, Oct. 2024, pp. 4449–58. EBSCOhost, https://doi.org/10.2147/DDDT.S480148.

APA

Wang, J., Wu, Y., Mao, M., Bing, H., Sun, L., Xu, W., Tian, W., Xia, Z., Jin, X., & Chu, Q. (2024). Sivelestat Sodium Alleviates Ischemia-Reperfusion-Induced Acute Kidney Injury via Suppressing TLR4/Myd88/NF-κB Signaling Pathway in Mice. Drug Design, Development & Therapy, 18, 4449–4458. https://doi.org/10.2147/DDDT.S480148

Chicago

Wang, Jie, Yuanbo Wu, Meng Mao, Hailong Bing, Liwei Sun, Wei Xu, Wangli Tian, Zhengyuan Xia, Xiaogao Jin, and Qinjun Chu. 2024. “Sivelestat Sodium Alleviates Ischemia-Reperfusion-Induced Acute Kidney Injury via Suppressing TLR4/Myd88/NF-ΚB Signaling Pathway in Mice.” Drug Design, Development & Therapy 18 (October): 4449–58. doi:10.2147/DDDT.S480148.